Charles Schwab’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.8M | Sell |
437,841
-28,231
| -6% | -$892K | ﹤0.01% | 1849 |
|
|
2025
Q1 | $15.5M | Sell |
466,072
-5,956
| -1% | -$198K | ﹤0.01% | 1753 |
|
|
2024
Q4 | $16.2M | Buy |
472,028
+100,586
| +27% | +$3.46M | ﹤0.01% | 1801 |
|
|
2024
Q3 | $14.9M | Sell |
371,442
-3,266
| -0.9% | -$131K | ﹤0.01% | 1854 |
|
|
2024
Q2 | $11.3M | Buy |
374,708
+1,192
| +0.3% | +$36K | ﹤0.01% | 1984 |
|
|
2024
Q1 | $12.5M | Buy |
373,516
+54,349
| +17% | +$1.83M | ﹤0.01% | 1869 |
|
|
2023
Q4 | $10.3M | Buy |
319,167
+28,256
| +10% | +$913K | ﹤0.01% | 1967 |
|
|
2023
Q3 | $9.53M | Buy |
290,911
+42,736
| +17% | +$1.4M | ﹤0.01% | 1929 |
|
|
2023
Q2 | $8.73M | Buy |
248,175
+24,266
| +11% | +$854K | ﹤0.01% | 1967 |
|
|
2023
Q1 | $7.31M | Sell |
223,909
-1,783
| -0.8% | -$58.2K | ﹤0.01% | 2022 |
|
|
2022
Q4 | $12.4M | Sell |
225,692
-30,014
| -12% | -$1.65M | ﹤0.01% | 1728 |
|
|
2022
Q3 | $11.3M | Buy |
255,706
+20,382
| +9% | +$903K | ﹤0.01% | 1768 |
|
|
2022
Q2 | $11.5M | Sell |
235,324
-25,067
| -10% | -$1.22M | ﹤0.01% | 1767 |
|
|
2022
Q1 | $12.7M | Sell |
260,391
-6,658
| -2% | -$324K | ﹤0.01% | 1819 |
|
|
2021
Q4 | $11.4M | Buy |
267,049
+35,020
| +15% | +$1.49M | ﹤0.01% | 1937 |
|
|
2021
Q3 | $8.89M | Buy |
232,029
+184,652
| +390% | +$7.08M | ﹤0.01% | 2076 |
|
|
2021
Q2 | $1.34M | Buy |
47,377
+33,610
| +244% | +$949K | ﹤0.01% | 2832 |
|
|
2021
Q1 | $455K | Buy |
13,767
+821
| +6% | +$27.1K | ﹤0.01% | 3110 |
|
|
2020
Q4 | $468K | Buy |
+12,946
| New | +$468K | ﹤0.01% | 3010 |
|